03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Stivant 400mg : | |
Type | Medicine Authorised |
Originator | Avastin 400mg |
Agent | Lebiran |
Distributor | Lebiran |
Laboratory | Aryogen |
Responsible Party | Aryogen Pharmed |
Origin | Iran |
Manufacturer | Aryogen Pharmed |
Manufacturing Type | G |
Origin | Iran |
ATC | L01XC07 |
Stivant 400mg :
Stivant 400mg :
Stivant 400mg :
Stivant 400mg :
Stivant 400mg :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain | Very Common |
Abscess | Common |
Anaemia | Common |
Anorexia | Very Common |
Arthralgia (Pain joint) (Joint ache) | Very Common |
Asthenia | Very Common |
Back pain | Common |
Cellulitis | Common |
Cephalea | Very Common |
Cerebrovascular accident | Common |
Congestive heart failure | Common |
Constipation | Very Common |
Deep vein thrombosis | Common |
Dehydration | Common |
Dermatitis exfoliative | Very Common |
Diarrhoea (Diarrhea) | Very Common |
Dry mouth (Xerostomia) | Very Common |
Dysarthria | Very Common |
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) | Very Common |
Dyspnoea (dyspnea) | Very Common |
Epistaxis (Nasal bleeding) | Very Common |
Eye disorder | Very Common |
Fatigue | Very Common |
Febrile neutropenia (Neutropenic fever) | Very Common |
Gastrointestinal disorders | Common |
Haemorrhage | Common |
Hand and foot syndrome (Palmar-plantar erythrodysaesthesia syndrome) | Common |
Hypertension | Very Common |
Hypoxia | Common |
Ileus | Common |
Infection | Common |
Intestinal obstruction | Common |
Intestinal perforation | Common |
Lacrimation increased (Epiphora) | Very Common |
Lethargy | Common |
Leucopenia (Leukopenia) | Very Common |
Lymphopenia | Common |
Mucosal inflammation | Very Common |
Muscle weakness | Common |
Myalgia | Common |
Nausea | Very Common |
Neutropenia | Very Common |
Ovarian insufficiency | Very Common |
Pain | Very Common |
Pelvic pain | Common |
Peripheral sensory neuropathy | Very Common |
Proctalgia | Common |
Proteinuria | Very Common |
Pulmonary embolism | Common |
Pyrexia | Very Common |
Recto-vaginal fistulae | Common |
Rectorrhagia | Very Common |
Rhinitis | Very Common |
Septicemia | Common |
Somnolence | Common |
Stomatitis | Very Common |
Supraventricular tachyarrhythmia | Common |
Syncope | Common |
Thrombocytopenia (Thrombopenia) | Very Common |
Thromboembolism arterial | Common |
Tumour necrosis | Very Common |
Urinary tract infection | Common |
Vomiting | Very Common |
Weight decreased (Weight loss) | Very Common |
Stivant 400mg :
▲ Most Expensive |
▼ Least Expensive |
P.P. = | Public Price |
P/U = | Price Per Unit |
- Products with same active ingredients |
- Products with same strength |
- Products with same route of administration |
NB : Products With Same Indication |
Different Units By MoH Code
Stivant 400mg MoH 10325 :
Form | Concentrate for solution for infusion |
Packaging | Bottle |
Package Size | 1x16ml |
Strength | 400mg |
Public Price | 27359527.21 L.L. |
Stratum | E1 |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 175319/1 |
Submission date | 2020 |
Registration Year | 05/01/2021 |
Price Comparison
● Country: | Lebanon | |
● Form: | Concentrate for solution for infusion | |
● Package Size: | 1x16ml | |
● Public Price: | 27359527.21 LBP | ( 27,359,527.21 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 27359527,21 LBP | ( 27,359,527.00 LBP ) |
● Pricing Date: | 13/06/2024 |
You have to register to view this info
Drop File